| Descriptor English: | Cyclin-Dependent Kinase Inhibitor p57 | ||||
| Descriptor Spanish: |
Inhibidor p57 de las Quinasas Dependientes de la Ciclina
| ||||
| Descriptor Portuguese: | Inibidor de Quinase Dependente de Ciclina p57 | ||||
| Descriptor French: | Inhibiteur p57 de kinase cycline-dépendante | ||||
| Entry term(s): |
CDKN1C Protein Cyclin Dependent Kinase Inhibitor 1C Cyclin Dependent Kinase Inhibitor p57 Cyclin Kinase Inhibitor Protein 2 Cyclin-Dependent Kinase Inhibitor 1C KIP2 Protein, p57 p57 KIP2 Protein p57KIP2 Protein |
||||
| Tree number(s): |
D12.644.360.225.700 D12.776.167.187.700 D12.776.476.225.700 D12.776.624.776.355.700 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D050761 | ||||
| Scope note: | A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME. |
||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
| Pharm Action: |
Protein Kinase Inhibitors |
||||
| Public MeSH Note: | 2006; CYCLIN-DEPENDENT KINASE INHIBITOR P57 was indexed under NUCLEAR PROTEINS 1995-2005 |
||||
| History Note: | 2006(1995) |
||||
| DeCS ID: | 50933 | ||||
| Unique ID: | D050761 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 2006/01/01 | ||||
| Date of Entry: | 2005/06/30 | ||||
| Revision Date: | 2015/11/23 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Cyclin-Dependent Kinase Inhibitor p57
- Preferred
| Concept UI |
M0245969 |
| Scope note | A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME. |
| Preferred term | Cyclin-Dependent Kinase Inhibitor p57 |
| Entry term(s) |
CDKN1C Protein Cyclin Dependent Kinase Inhibitor 1C Cyclin Dependent Kinase Inhibitor p57 Cyclin Kinase Inhibitor Protein 2 Cyclin-Dependent Kinase Inhibitor 1C KIP2 Protein, p57 p57 KIP2 Protein p57KIP2 Protein |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
